Comparison Between the Health Effects of an AI-driven Model With Those of Human Professional Guidelines for the Treatment of Obesity

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorTexas Tech University

About this trial

Many non-communicable diseases are diet-related and have a significant impact on public health. It is stated that global dietary shifts are needed to change disease patterns, highlighting the importance of nutrition in addressing public health issues, such as obesity. The field of nutrition has been dependent on clinical and observational studies; however, the emergence of Artificial Intelligence (AI) is transforming these approaches.

ChatGPT may be used to provide dietary recommendations due to its high speed, extensive access to a variety of meal data, and low complexity. However, initial evaluations have shown that ChatGPT may be inaccurate in terms of safety and reliability, and traditional nutrition approaches are highly reliant on experts' knowledge and the validity of nutritional guidelines. It has been suggested that AI in nutrition may be beneficial; however, further investigations are needed. Our proposal aims to fill the represented critical evidence gaps.

The study aims to compare the health effects of an AI-driven model with those of human professional guidelines for the treatment of obesity. Furthermore, investigators seek better strategies to utilize AI, if appropriate, for weight loss and other health benefits.

Eligibility criteria

Qualifiers

Participants with age 18 to 60 years,

BMI>30

Living in Lubbock-TX

Willing to participate in the study

Disqualifiers

Pregnant women

Breastfeeding women

Recent diagnosis of a severe/acute medical condition within 6 months

Any other chronic diseases except obesity (e.g., diabetes, chronic kidney diseases, psychiatric conditions, cancer, acute pancreatitis)

Trial design

Treatments tested in this trial

  • AI-assisted dietitian group (combination)
  • A dietitian-led group (human)
  • AI-only group using ChatGPT Premium

Treatment groups

21 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators